Published in Circulation on September 26, 2005
Remote Ischemic Postconditioning in Humans | NCT01113008
Post-conditioning to Reduce Infarct Size | NCT00755469
Postconditioning in Primary PCI and Direct Stenting | NCT00351247
Ischemic Conditioning in STEMI Patients (EDICT) | NCT03097419
Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64
Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest (2013) 2.83
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol (2010) 2.52
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies. Cardiovasc Res (2014) 2.24
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev (2007) 2.14
Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res (2009) 2.10
Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res (2007) 2.01
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol (2010) 1.88
Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab (2009) 1.77
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth (2012) 1.52
Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World J Cardiol (2011) 1.51
Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovasc Drugs Ther (2013) 1.51
Cardiovascular remodelling in coronary artery disease and heart failure. Lancet (2014) 1.47
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol (2010) 1.37
Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart (2007) 1.30
Coronary microvascular dysfunction: an update. Eur Heart J (2013) 1.28
Reperfusion injury: does it exist? J Mol Cell Cardiol (2006) 1.27
Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol (2008) 1.25
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol (2012) 1.21
Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal (2010) 1.17
Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. Am J Physiol Heart Circ Physiol (2006) 1.13
Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J (2014) 1.11
Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res (2009) 1.10
The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. J Mol Cell Cardiol (2014) 1.10
Inhibition of autophagy contributes to ischemic postconditioning-induced neuroprotection against focal cerebral ischemia in rats. PLoS One (2012) 1.09
MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res (2011) 1.09
Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol (2016) 1.08
From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia. Curr Drug Targets (2012) 1.08
Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation (2008) 1.08
The paradigm of postconditioning to protect the heart. J Cell Mol Med (2007) 1.07
Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J Cardiovasc Pharmacol Ther (2012) 1.04
Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc Drugs Ther (2010) 1.04
Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res (2013) 1.03
Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion. Eur Heart J (2009) 1.03
Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation (2005) 1.02
Reducing myocardial infarct size: challenges and future opportunities. Heart (2015) 1.00
Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest (2015) 1.00
A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol (2008) 0.98
Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev (2007) 0.97
The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.96
Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail Rev (2007) 0.95
Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther (2014) 0.95
Ischemia-reperfusion injury in stroke. Interv Neurol (2013) 0.94
Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1. Cardiovasc Diabetol (2014) 0.94
Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev (2007) 0.94
Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial. J Am Heart Assoc (2014) 0.93
Myocardial protection in man--from research concept to clinical practice. Heart Fail Rev (2007) 0.92
Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future. Br J Pharmacol (2014) 0.90
Ischaemic conditioning: pitfalls on the path to clinical translation. Br J Pharmacol (2015) 0.89
Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr Med Chem (2009) 0.89
Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase δ and Echs1. J Cell Mol Med (2012) 0.89
Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circ Res (2014) 0.89
Postconditioning signalling in the heart: mechanisms and translatability. Br J Pharmacol (2014) 0.88
Hydrogen sulfide-mediated myocardial pre- and post-conditioning. Expert Rev Clin Pharmacol (2011) 0.87
The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial. BMJ Open (2013) 0.87
Mild hypothermia reduces cardiac post-ischemic reactive hyperemia. BMC Cardiovasc Disord (2007) 0.87
Anesthetic cardioprotection: the role of adenosine. Curr Pharm Des (2014) 0.87
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol (2016) 0.87
Non-pharmaceutical therapies for stroke: mechanisms and clinical implications. Prog Neurobiol (2014) 0.86
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation. J Transplant (2012) 0.86
The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism. Br J Pharmacol (2015) 0.85
Endogenous cardioprotection by ischaemic postconditioning and remote conditioning. Cardiovasc Res (2012) 0.85
Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart. Cardiovasc Drugs Ther (2013) 0.85
Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol (2015) 0.85
Remote conditioning the heart overview: translatability and mechanism. Br J Pharmacol (2014) 0.84
The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol (2008) 0.84
Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning. Am J Physiol Heart Circ Physiol (2011) 0.84
Novel adjunctive treatments of myocardial infarction. World J Cardiol (2014) 0.84
A small molecule activator of AKT does not reduce ischemic injury of the rat heart. J Transl Med (2015) 0.84
Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. J Am Heart Assoc (2013) 0.84
Very short cycles of postconditioning have no protective effect against reperfusion injury. Experimental study in rats. Rev Bras Cir Cardiovasc (2015) 0.83
Ischemic postconditioning influences electron transport chain protein turnover in Langendorff-perfused rat hearts. PeerJ (2016) 0.83
The Protective Effects of Ischemic Postconditioning against Stroke: From Rapid to Delayed and Remote Postconditioning. Open Drug Discov J (2011) 0.83
Long-term protection and mechanism of pacing-induced postconditioning in the heart. Basic Res Cardiol (2010) 0.83
Protection of the ischemic myocardium during the reperfusion: between hope and reality. Am J Cardiovasc Dis (2012) 0.83
Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging (2013) 0.83
Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration. Arch Med Sci (2013) 0.82
Nonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decreases reperfusion injury. Am J Physiol Heart Circ Physiol (2009) 0.82
Postconditioning ameliorates mitochondrial DNA damage and deletion after renal ischemic injury. Nephrol Dial Transplant (2013) 0.82
Effect of morphine-induced postconditioning in corrections of tetralogy of fallot. J Cardiothorac Surg (2013) 0.82
Ischemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2. Exp Mol Med (2011) 0.82
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial. J Transl Med (2014) 0.81
Adjuvant cardioprotection in cardiac surgery: update. Biomed Res Int (2014) 0.81
microRNA expression and its potential role in cardioprotection by ischemic postconditioning in pigs. Pflugers Arch (2014) 0.81
Redox signalling and cardioprotection: translatability and mechanism. Br J Pharmacol (2015) 0.81
The pleiotropic effects of metformin: time for prospective studies. Cardiovasc Diabetol (2015) 0.80
Postconditioning hormesis put in perspective: an overview of experimental and clinical studies. Dose Response (2010) 0.80
The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease. Basic Res Cardiol (2014) 0.80
The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury. Heart (2007) 0.80
Letter regarding article by Staat et al, "postconditioning the human heart". Circulation (2006) 0.80
Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning. Basic Res Cardiol (2014) 0.80
Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial. Int J Cardiovasc Imaging (2015) 0.80
Ischemic postconditioning does not provide cardioprotection from long-term ischemic injury in isolated male or female rat hearts. J Surg Res (2010) 0.79
Postconditioning against ischaemia-reperfusion injury: ready for wide application in patients? Neth Heart J (2010) 0.79
The effects of ischemic postconditioning on myocardial function and nitric oxide metabolites following ischemia-reperfusion in hyperthyroid rats. Korean J Physiol Pharmacol (2014) 0.79
Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials. Vasc Health Risk Manag (2014) 0.79
Remote limb ischemic conditioning enhances motor learning in healthy humans. J Neurophysiol (2015) 0.79
A minimally-invasive closed chest myocardial occlusion-reperfusion model in rhesus monkeys (Macaca mulatta): monitoring by contrast-enhanced ultrasound imaging. Int J Cardiovasc Imaging (2011) 0.78
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90
Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med (2014) 4.37
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation (2003) 4.25
Postconditioning inhibits mitochondrial permeability transition. Circulation (2005) 3.30
Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med (2012) 2.88
Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular Project (DIVA). Heart (2010) 2.83
Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2012) 2.68
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol (2010) 2.54
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation (2008) 2.17
Assessment of left ventricular systolic function by deformation imaging derived from speckle tracking: a comparison between 2D and 3D echo modalities. Eur Heart J Cardiovasc Imaging (2013) 2.10
Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation (2008) 2.02
Takotsubo Cardiomyopathy Following Acute Cerebral Events. Eur Neurol (2015) 1.98
Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol (2005) 1.92
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2013) 1.72
Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. J Clin Endocrinol Metab (2010) 1.68
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Long-term benefit of postconditioning. Circulation (2008) 1.65
Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol (2013) 1.59
Delayed postconditioning in the mouse heart in vivo. Circulation (2011) 1.58
Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol (2008) 1.58
QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol (2003) 1.56
High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. J Am Coll Cardiol (2007) 1.56
Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction. Heart Lung (2013) 1.53
How reliable are 40 MHz IVUS and 64-slice MDCT in characterizing coronary plaque composition? An ex vivo study with histopathological comparison. Int J Cardiovasc Imaging (2010) 1.50
Level of adenosine diphosphate receptor P2Y12 blockade during percutaneous coronary intervention predicts the extent of endothelial injury, assessed by circulating endothelial cell measurement. J Am Coll Cardiol (2010) 1.44
Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant (2010) 1.42
ER stress inhibits neuronal death by promoting autophagy. Autophagy (2012) 1.39
Influence of residual stress/strain on the biomechanical stability of vulnerable coronary plaques: potential impact for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol (2007) 1.38
Biomechanical interaction between cap thickness, lipid core composition and blood pressure in vulnerable coronary plaque: impact on stability or instability. Coron Artery Dis (2004) 1.38
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol (2010) 1.37
Prognostic value of ST-segment resolution after rescue percutaneous coronary intervention. Data from the RICO survey. Catheter Cardiovasc Interv (2008) 1.37
PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res (2005) 1.34
Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med (2005) 1.33
French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart (2012) 1.31
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther (2013) 1.28
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
Preconditioning delays Ca2+-induced mitochondrial permeability transition. Cardiovasc Res (2004) 1.22
Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D. Biochim Biophys Acta (2012) 1.21
Longitudinal strain quantitates regional right ventricular contractile function. Am J Physiol Heart Circ Physiol (2003) 1.19
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2007) 1.18
Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol (2008) 1.10
Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential. J Mol Cell Cardiol (2009) 1.10
Influence of afterload on left ventricular radial and longitudinal systolic functions: a two-dimensional strain imaging study. Eur J Echocardiogr (2009) 1.10
Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol (2009) 1.10
Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr (2011) 1.09
Epstein Barr virus (EBV) and acute myopericarditis in an immunocompetent patient: first demonstrated case and discussion. Intern Med (2008) 1.09
Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J Am Soc Echocardiogr (2010) 1.09
Myocardial Salvage, Area at Risk by T2w CMR: The Resolution of the Retrospective Radio Wave Paradigm? J Am Coll Cardiol (2015) 1.08
Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential. Mol Nutr Food Res (2013) 1.07
Inhibition of mitochondrial permeability transition to prevent the post-cardiac arrest syndrome: a pre-clinical study. Eur Heart J (2010) 1.06
The right axillary artery approach for the Impella Recover LP 5.0 microaxial pump. Ann Thorac Surg (2008) 1.06
Vulnerable atherosclerotic plaque elasticity reconstruction based on a segmentation-driven optimization procedure using strain measurements: theoretical framework. IEEE Trans Med Imaging (2009) 1.05
Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res (2009) 1.05
Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care (2005) 1.04